EHMT2 and Miyoshi myopathy: In particular, inhibition of euchromatic histone-lysine N-methyltransferase 2 (EHMT2) has been demonstrated as a valuable strategy to enhance PI sensitivity and overcome drug resistance in MM patients [70, 71].